Free Trial

AlloVir (ALVR) SEC Filings & 10K Form

AlloVir logo
$7.71 +0.64 (+9.05%)
As of 04/9/2025

Recent AlloVir SEC Filings

DateFilerForm TypeView
04/04/2025
7:21 AM
AlloVir (Issuer)
PATTERSON LEONE D (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
04/04/2025
7:12 AM
AlloVir (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/27/2025
6:19 PM
Hagen Brett R (Reporting)
AlloVir (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/26/2025
4:06 PM
AKKARAJU SRINIVAS (Reporting)
AlloVir (Issuer)
Form 3/A
03/25/2025
6:38 PM
AlloVir (Issuer)
Samsara BioCapital GP, LLC (Reporting)
Samsara BioCapital, L.P. (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
03/25/2025
6:40 PM
AlloVir (Subject)
Samsara BioCapital, L.P. (Filed by)
Form SCHEDULE 13D
03/20/2025
3:32 PM
GILEAD SCIENCES, INC. (Filed by)
AlloVir (Subject)
Form SCHEDULE 13G/A
03/18/2025
4:44 PM
AlloVir (Issuer)
PATEL SAMIR CHANDRAKANT (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/18/2025
4:45 PM
Ferrara Napoleone (Reporting)
AlloVir (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/18/2025
4:37 PM
ADAMIS ANTHONY P (Reporting)
AlloVir (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/18/2025
4:40 PM
AKKARAJU SRINIVAS (Reporting)
AlloVir (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/18/2025
4:41 PM
AlloVir (Issuer)
Oxtoby Andrew (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/18/2025
4:43 PM
Feinsod Matthew (Reporting)
AlloVir (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/18/2025
4:25 PM
Dybbs Michael (Reporting)
AlloVir (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
03/18/2025
4:27 PM
Ferrara Napoleone (Reporting)
AlloVir (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
03/18/2025
4:30 PM
AKKARAJU SRINIVAS (Reporting)
AlloVir (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
03/18/2025
4:14 PM
ADAMIS ANTHONY P (Reporting)
AlloVir (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
03/18/2025
4:17 PM
Feinsod Matthew (Reporting)
AlloVir (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
03/18/2025
4:20 PM
AlloVir (Issuer)
Oxtoby Andrew (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
03/18/2025
4:21 PM
AlloVir (Issuer)
PATEL SAMIR CHANDRAKANT (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
03/18/2025
4:04 PM
AlloVir (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/12/2025
3:18 PM
AlloVir (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/07/2025
6:30 AM
AlloVir (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/24/2025
10:51 AM
AlloVir (Subject)
Hagen Brett R (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/24/2025
10:55 AM
AlloVir (Subject)
Miller Edward (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/24/2025
10:56 AM
AlloVir (Subject)
Sinha Vikas (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/14/2025
12:17 PM
AlloVir (Subject)
EcoR1 Capital, LLC (Filed by)
Form SCHEDULE 13G/A
02/10/2025
11:15 PM
AlloVir (Filer)
Form EFFECT
02/10/2025
3:19 PM
AlloVir (Filer)
Form 424B3
01/24/2025
1:51 PM
AlloVir (Subject)
Hagen Brett R (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/24/2025
1:55 PM
AlloVir (Subject)
Miller Edward (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/24/2025
2:03 PM
AlloVir (Subject)
Sinha Vikas (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/15/2025
3:39 PM
AlloVir (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/15/2025
3:41 PM
AlloVir (Subject)
Form 425
01/13/2025
3:15 PM
AlloVir (Issuer)
Sinha Vikas (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/13/2025
3:15 PM
AlloVir (Issuer)
Hagen Brett R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/13/2025
3:15 PM
AlloVir (Issuer)
Miller Edward (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/10/2025
7:00 PM
AlloVir (Subject)
Hagen Brett R (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/10/2025
7:00 PM
AlloVir (Subject)
Sinha Vikas (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/10/2025
7:00 PM
AlloVir (Subject)
Miller Edward (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/10/2025
6:44 AM
AlloVir (Subject)
Form 425
Elon Musk Confirms: Tesla’s Optimus is Replacing Workers… and Heading to Mars (Ad)

Elon Musk just confirmed Tesla’s robot will go to Mars. But on Earth, it may trigger a trillion-dollar tech shift. Here’s how to position early.

Musk just lit the fuse on AI 2.0 — here's how to get ahead.
01/10/2025
6:42 AM
AlloVir (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/20/2024
3:21 PM
AlloVir (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/20/2024
3:23 PM
AlloVir (Subject)
Form 425
12/11/2024
4:07 PM
AlloVir (Issuer)
Miller Edward (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/09/2024
5:37 AM
AlloVir (Filer)
Form S-4
Registration statement under Securities Act of 1933  
12/06/2024
8:50 PM
AlloVir (Subject)
Form 425
12/06/2024
6:23 AM
AlloVir (Filer)
Form DEF 14A
11/20/2024
3:15 PM
AlloVir (Issuer)
Brainard Diana (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/20/2024
3:15 PM
AlloVir (Issuer)
Miller Edward (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/20/2024
3:15 PM
AlloVir (Issuer)
Sinha Vikas (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/20/2024
3:15 PM
AlloVir (Issuer)
Hagen Brett R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/19/2024
7:00 PM
AlloVir (Subject)
Hagen Brett R (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/19/2024
7:00 PM
AlloVir (Subject)
Brainard Diana (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/19/2024
7:00 PM
AlloVir (Subject)
Miller Edward (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/19/2024
7:00 PM
AlloVir (Subject)
Sinha Vikas (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/08/2024
3:05 PM
AlloVir (Subject)
Form 425
11/08/2024
3:06 PM
AlloVir (Subject)
Form 425
11/08/2024
3:09 PM
AlloVir (Subject)
Form 425
11/08/2024
3:10 PM
AlloVir (Subject)
Form 425
11/08/2024
7:26 AM
AlloVir (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/08/2024
7:33 AM
AlloVir (Subject)
Form 425
11/05/2024
7:00 PM
AlloVir (Subject)
Sinha Vikas (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/05/2024
7:00 PM
AlloVir (Subject)
Hagen Brett R (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/05/2024
7:00 PM
AlloVir (Subject)
Miller Edward (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/05/2024
7:00 PM
AlloVir (Subject)
Brainard Diana (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/23/2024
3:15 PM
AlloVir (Issuer)
Miller Edward (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/23/2024
3:15 PM
AlloVir (Issuer)
Hagen Brett R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/23/2024
3:15 PM
AlloVir (Issuer)
Sinha Vikas (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/23/2024
3:15 PM
AlloVir (Issuer)
Brainard Diana (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/22/2024
7:00 PM
AlloVir (Subject)
Sinha Vikas (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/22/2024
7:00 PM
AlloVir (Subject)
Miller Edward (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/22/2024
7:00 PM
AlloVir (Subject)
Hagen Brett R (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/21/2024
7:00 PM
AlloVir (Subject)
Miller Edward (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/21/2024
7:00 PM
AlloVir (Subject)
Brainard Diana (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/21/2024
7:00 PM
AlloVir (Subject)
Sinha Vikas (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/21/2024
7:00 PM
AlloVir (Subject)
Hagen Brett R (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/04/2024
3:15 PM
AlloVir (Issuer)
Hagen Brett R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/04/2024
3:15 PM
AlloVir (Issuer)
Brainard Diana (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/04/2024
3:15 PM
AlloVir (Issuer)
Miller Edward (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/04/2024
3:15 PM
AlloVir (Issuer)
Sinha Vikas (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/03/2024
7:00 PM
AlloVir (Subject)
Miller Edward (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/03/2024
7:00 PM
AlloVir (Subject)
Sinha Vikas (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/03/2024
7:00 PM
AlloVir (Subject)
Hagen Brett R (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/03/2024
7:00 PM
AlloVir (Subject)
Brainard Diana (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/22/2024
3:15 PM
AlloVir (Issuer)
Brainard Diana (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/21/2024
10:14 AM
AlloVir (Subject)
Brainard Diana (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/20/2024
3:15 PM
AlloVir (Issuer)
Brainard Diana (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/20/2024
3:15 PM
AlloVir (Issuer)
Sinha Vikas (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/20/2024
3:15 PM
AlloVir (Issuer)
Hagen Brett R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/20/2024
3:15 PM
AlloVir (Issuer)
Miller Edward (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
Warning: “DOGE Collapse” imminent (Ad)

Elon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week, President Trump promised to buy a Tesla to help support Musk in the face of a boycott against his company. But according to one research group, with connections to the Pentagon and the U.S. government, Elon's preparing to strike back in a much bigger way in the days ahead.

Click here to see what they’re predicting now.
08/19/2024
7:00 PM
AlloVir (Subject)
Sinha Vikas (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/19/2024
7:00 PM
AlloVir (Subject)
Hagen Brett R (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/19/2024
7:00 PM
AlloVir (Subject)
Miller Edward (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/19/2024
7:00 PM
AlloVir (Subject)
Brainard Diana (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/09/2024
8:05 AM
AlloVir (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/07/2024
3:15 PM
AlloVir (Issuer)
Hagen Brett R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/07/2024
3:15 PM
AlloVir (Issuer)
Sinha Vikas (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/07/2024
3:15 PM
AlloVir (Issuer)
Brainard Diana (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/07/2024
3:15 PM
AlloVir (Issuer)
Miller Edward (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
(Data available from 1/1/2016 forward)

Remove Ads

Related Companies and Tools


This page (NASDAQ:ALVR) was last updated on 4/10/2025 by MarketBeat.com Staff
From Our Partners